云南省药品流通行业发展研究
发布时间:2018-04-16 06:34
本文选题:云南省 + 药品流通行业 ; 参考:《云南财经大学》2013年硕士论文
【摘要】:在人们公认的21世纪两大主导产业中,一个是信息产业,另一个即是生物工程产业。云南是我国著名的生物资源富集区,享有“植物王国”、“香料王国”、“花卉之乡”、“药物宝库”、“生物资源基因库”等美誉。云南生物资源品种之丰富,储量及发展潜力之大,,均为全国之冠。医药流通业作为药品从生产企业到达医院、药店等销售终端的必经环节,是药品市场扩容的最直接受益者,在拥有如此优势的情况下,云南药品流通行业是否能够抓住这个千载难逢的机遇,如何发展必将对云南医药行业的发展起到至关重要的作用,本文就此进行一定的研究,希望能够推动云南省的医药发展更上一个新的台阶。 本文通过分析云南省药品流通行业的发展现状,进而分析了药品流通行业发展中存在的问题。然后通过对药品流通行业发展进行SWOT分析,分析了药品流通业发展的优势、劣势、机遇和挑战。同时借鉴国内外药品流通行业发展经验,针对药品流通行业发展中存在问题提出解决对策:理顺药品流通行业发展管理体制、调整云南省药品流通行业发展布局、提高云南省药品流通行业流通组织化现代化水平、突出特色,完善网络,建设高效物流体系、做大流通主体,增强企业竞争实力、突出我省药品流通行业发展特色、开拓国际市场,加快“走出去”步伐、启动“药品流通信息系统”建设。
[Abstract]:Among the two leading industries in the 21st century, one is information industry and the other is bioengineering industry.Yunnan is a famous rich region of biological resources in China. Yunnan enjoys the reputation of "plant kingdom", "spice kingdom", "hometown of flowers", "treasure house of medicine", "gene bank of biological resources" and so on.Yunnan biological resources are rich in species, reserves and development potential, are the top in the country.The pharmaceutical circulation industry is the most direct beneficiary of the expansion of the pharmaceutical market as a necessary link for the pharmaceutical industry to reach the sales terminals such as hospitals and pharmacies from the manufacturing enterprises. Under the circumstances of such advantages,Whether Yunnan pharmaceutical circulation industry can seize this once-in-a-lifetime opportunity and how to develop it will play a vital role in the development of Yunnan pharmaceutical industry.I hope to promote the development of medicine in Yunnan Province to a new level.This paper analyzes the current situation of drug circulation industry in Yunnan Province, and then analyzes the problems existing in the development of drug circulation industry.Then, through the SWOT analysis of the development of the drug circulation industry, the advantages, disadvantages, opportunities and challenges of the development of the drug circulation industry are analyzed.At the same time, referring to the development experience of drug circulation industry at home and abroad, the paper puts forward some countermeasures to solve the problems existing in the development of drug circulation industry: straightening out the development management system of drug circulation industry and adjusting the development layout of drug circulation industry in Yunnan Province.To improve the level of organized modernization of drug circulation in Yunnan Province, to highlight the characteristics, to perfect the network, to build an efficient logistics system, to enlarge the circulation subject, to enhance the competitive strength of enterprises, and to highlight the characteristics of the development of the pharmaceutical circulation industry in our province.Open up the international market, speed up the pace of "going out", and start the construction of "Drug Circulation Information system".
【学位授予单位】:云南财经大学
【学位级别】:硕士
【学位授予年份】:2013
【分类号】:F426.72;F724
【参考文献】
相关期刊论文 前10条
1 胡正荣;产业整合与跨世纪变革——美国广播电视业的发展走向[J];国际新闻界;1999年04期
2 陈文玲;有序推进药品流通体制改革[J];国际医药卫生导报;2005年03期
3 刘震;胡凯;;克服药品流通领域弊端对策的探讨[J];管理科学文摘;2005年02期
4 朱险峰;药品流通体制改革中的新问题[J];医院管理论坛;2004年11期
5 范乔阳,钟敏;药品生产与流通体制改革问题探讨[J];中国卫生经济;2002年02期
6 张有梨,王香华;药品流通与管理方面几个问题的探讨[J];中国卫生质量管理;2004年05期
7 付昕;袁杰;;构建我国药品流通渠道新模式的设想[J];卫生经济研究;2007年01期
8 郭有德;医疗费用上涨原因及控制对策研究[J];中国卫生资源;2005年03期
9 张敬东;加强药品流通行为规范管理的几点建议[J];药学实践杂志;2001年01期
10 黄佑 ,冯国忠;怎样降低药品流通成本?[J];医药世界;2003年06期
本文编号:1757686
本文链接:https://www.wllwen.com/guanlilunwen/shengchanguanlilunwen/1757686.html